Trial intelligence / Profile preview

Higher-dose Clomid versus highly purified hMG for ovulation induction non-response

2008-006372-29Phase 4Completed

Sponsor
Christophe Blockeel
Start
Nov 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in anovulatory infertility and ovulation disorder comparing Increased-dose Clomid 100 mg with Highly purified hMG (2 arms). Primary endpoint: Folliculogenesis in each treatment group. Started Nov 2008; status: completed.

02

Drugs

clomiphenehuman menopausal gonadotrophin
03

Conditions

anovulatory infertilityovulation disorder

Beyond the preview

Go deeper on 2008-006372-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-006372-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call